EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Natalizumab (exclusively infusion solution concentrate), ATC L04AG03 for the period 01.12.2026 - 30.11.2028
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AG03 für die Zeit 01.12.2026 - 30.11.2028
EU-wide public tender in Germany: “Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Natalizumab (exclusively infusion solution concentrate), ATC L04AG03 for the period 01.12.2026 - 30.11.2028”. Offers are due by Thursday, 5 October 2028, in 704 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 October 2028, 704 days left, 12:00
- Published
- 15 October 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit is concluding a non-exclusive discount agreement for the medicinal product Natalizumab.
- The contract period is from 1 December 2026 to 30 November 2028.
- The agreement can be concluded by all pharmaceutical companies at any time under the same conditions.
- The tender documents must be submitted by email to a specific address.
- For participation to begin at the start of a month, the documents must be received by the 5th of the preceding month.
- The procedure automatically ends upon the entry into force of a subsequent exclusive contract.
Summary made from the German notice and checked against it; the German original is authoritative.
Conditions stated in the notice
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
What stands out
The notice links the tender documents directly. The contract runs for 24 months.
Questions and answers
When is the deadline for offers?
Until Thursday, 5 October 2028, 704 days left. The exact time and how to submit are in the original notice, which is authoritative.
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Dates of this tender
| Published | Thursday, 15 October 2026 |
|---|---|
| Deadline | Thursday, 5 October 2028, 12:00 |
| Tender validity ends (calculated) | Saturday, 4 November 2028 |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.